TCR2 Therapeutics

-$0.05 (-0.26%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TCRR and other stocks, options, and ETFs commission-free!

About TCRR

TCR2 Therapeutics Inc. Common Stock, also called TCR2 Therapeutics, is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy.

CEO
Garry E. Menzel
Employees
118
Headquarters
Cambridge, Massachusetts
Founded
2015

TCRR Key Statistics

Market Cap
795.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
304.91K
High Today
$19.85
Low Today
$18.70
Open Price
$18.90
Volume
215.85K
52 Week High
$35.86
52 Week Low
$8.71

TCRR Earnings

-$0.67
-$0.45
-$0.22
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, Pre-Market

You May Also Like

FOCS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure